Updates from The Motley Fool

Latest updates on Epizyme from Fool.com.


Stock Performance

EPZM vs. S&P 500 | 2 Year Performance
EPZM 1-Day Stock Chart
EPZM 5-Day Stock Chart
EPZM 1-Month Stock Chart
EPZM 3-Month Stock Chart
EPZM 6-Month Stock Chart
EPZM 1-Year Stock Chart
EPZM 2-Year Stock Chart
EPZM 5-Year Stock Chart
View Interactive EPZM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Epizyme.
Current Price: $9.54
Prev Close: $9.88
Open: $9.65
Bid: $9.21
Ask: $9.25
Day's Range: $9.09 - $9.68
52wk Range: $8.27 - $28.48
Volume: 352,371
Avg Vol 324,204
Market Cap: $397.85M
P/E (ttm): -2.97
EPS (ttm): -$3.32
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Epizyme.
CAPS Rating 4 out of 5
 
43 Outperform
5 Underperform
CAPS All Stars
 
15 Outperform
2 Underperform

How do you think Epizyme will perform against the market?



You pick for Epizyme is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Epizyme.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

  • Exchange: NASDAQ